Home/Filings/4/0001209191-15-020518
4//SEC Filing

THRESHOLD PHARMACEUTICALS INC 4

Accession 0001209191-15-020518

CIK 0001183765operating

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 7:53 PM ET

Size

5.4 KB

Accession

0001209191-15-020518

Insider Transaction Report

Form 4
Period: 2015-02-26
Pearce Tillman
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2015-02-26+160,000160,000 total
    Exercise: $4.43Exp: 2025-02-25Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]The option vests in 48 equal monthly installments over a four-year period beginning on the date of grant of February 26, 2015.

Issuer

THRESHOLD PHARMACEUTICALS INC

CIK 0001183765

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001183765

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:53 PM ET
Size
5.4 KB